NaV1.7 and pain: contribution of peripheral nerves

被引:29
|
作者
Hoffmann, Tal [1 ]
Sharon, Ohad [1 ]
Wittmann, Juergen [2 ]
Carr, Richard W. [3 ]
Vyshnevska, Alina [3 ]
De Col, Roberto [1 ]
Nassar, Mohammed A. [4 ]
Reeh, Peter W. [1 ]
Weidner, Christian [1 ,5 ]
机构
[1] Univ Erlangen Nurnberg, Inst Physiol & Pathophysiol, Univ Str 17, D-91054 Erlangen, Germany
[2] Univ Erlangen Nurnberg, Div Mol Immunol, Dept Internal Med 3, Ctr Mol Med,Nikolaus Fiebiger, Erlangen, Germany
[3] Heidelberg Univ, Dept Anaesthesiol & Operat Intens Care, Mannheim, Germany
[4] Univ Sheffield, Dept Biomed Sci, Sheffield, S Yorkshire, England
[5] Bavarian State Author Hlth & Food Safety, Erlangen, Germany
关键词
Voltage-gated sodium channels; Unmyelinated fibers; CGRP release; Compound action potential; Plantar test; von Frey test; DORSAL-ROOT GANGLION; ACTION-POTENTIAL ELECTROGENESIS; CLOSED-STATE INACTIVATION; VELOCITY RECOVERY CYCLES; PAROXYSMAL EXTREME PAIN; SODIUM-CHANNEL NA(V)1.7; PRIMARY SENSORY NEURONS; OF-FUNCTION MUTATIONS; UNMYELINATED FIBERS; RAT SKIN;
D O I
10.1097/j.pain.0000000000001119
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
The sodium channel Na(V)1.7 contributes to action potential (AP) generation and propagation. Loss-of-function mutations in patients lead to congenital indifference to pain, though it remains unclear where on the way from sensory terminals to central nervous system the signalling is disrupted. We confirm that conditional deletion of Na(V)1.7 in advillin-expressing sensory neurons leads to impaired heat and mechanical nociception in behavioural tests. With single-fiber recordings from isolated skin, we found (1) a significantly lower prevalence of heat responsiveness to normally mechanosensitive C-fibers, although (2) the rare heat responses seemed quite vigorous, and (3) heat-induced calcitonin gene-related peptide release was normal. In biophysical respects, although electrical excitability, rheobase, and chronaxy were normal, (4) axonal conduction velocity was 20% slower than in congenic wild-type mice (5) and when challenged with double pulses (< 100 milliseconds interval), the second AP showed more pronounced latency increase (6). On prolonged electrical stimulation at 2 Hz, (7) activity-dependent slowing of nerve fiber conduction was markedly less, and (8) was less likely to result in conduction failure of the mutant single fibers. Finally, recording of compound APs from the whole saphenous nerve confirmed slower conduction and less activity-dependent slowing as well as the functional absence of a large subpopulation of C-fibers (9) in conditional Na(V)1.7(Adv) knockouts. In conclusion, the clear deficits in somatic primary afferent functions shown in our study may be complemented by previously reported synaptic dysfunction and opioidergic inhibition, together accounting for the complete insensitivity to pain in the human mutants lacking Na(V)1.7.
引用
收藏
页码:496 / 506
页数:11
相关论文
共 50 条
  • [31] Identification and targeting of a unique NaV1.7 domain driving chronic pain
    Gomez, Kimberly
    Stratton, Harrison J.
    Duran, Paz
    Loya, Santiago
    Tang, Cheng
    Calderon-Rivera, Aida
    Francois-Moutal, Liberty
    Khanna, May
    Madura, Cynthia L.
    Luo, Shizhen
    McKiver, Bryan
    Choi, Edward
    Ran, Dongzhi
    Boinon, Lisa
    Perez-Miller, Samantha
    Damaj, M. Imad
    Moutal, Aubin
    Khanna, Rajesh
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2023, 120 (32)
  • [32] Familial pain syndromes from mutations of the Nav1.7 sodium channel
    Fischer, Tanya Z.
    Waxman, Stephen G.
    YEAR IN NEUROLOGY 2, 2010, 1184 : 196 - 207
  • [33] Interplay of Nav1.8 and Nav1.7 channels drives neuronal hyperexcitability in neuropathic pain
    Vasylyev, Dmytro V.
    Zhao, Peng
    Schulman, Betsy R.
    Waxman, Stephen G.
    JOURNAL OF GENERAL PHYSIOLOGY, 2024, 156 (11):
  • [34] Targeting Nav1.7 and Nav1.8 with a PIKfyve inhibitor to reverse inflammatory and neuropathic pain
    Rodriguez-Palma, Erick J.
    Loya-Lopez, Santiago
    Min, Sophia M.
    Calderon-Rivera, Aida
    Gomez, Kimberly
    Khanna, Rajesh
    Axtman, Alison D.
    NEUROBIOLOGY OF PAIN, 2025, 17
  • [35] NaV1.7 as a Pharmacogenomic Target for Pain: Moving Toward Precision Medicine
    Yang, Yang
    Mis, Malgorzata A.
    Estacion, Mark
    Dib-Hajj, Sulayman D.
    Waxman, Stephen G.
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2018, 39 (03) : 258 - 275
  • [36] Structural mapping of Nav1.7 antagonists
    Qiurong Wu
    Jian Huang
    Xiao Fan
    Kan Wang
    Xueqin Jin
    Gaoxingyu Huang
    Jiaao Li
    Xiaojing Pan
    Nieng Yan
    Nature Communications, 14
  • [37] Development of an equipotent NaV1.1 and NaV1.7 inhibitor for the treatment of chronic visceral pain
    Eagles, David
    King, Glenn
    Cardoso, Fernanda
    Muttenthaler, Markus
    Brierley, Stuart
    JOURNAL OF PEPTIDE SCIENCE, 2024, 30
  • [38] Neuropathic pain develops normally in mice lacking both Nav1.7 and Nav1.8
    Nassar, Mohammed A.
    Levato, Alessandra
    Stirling, L. Caroline
    Wood, John N.
    MOLECULAR PAIN, 2005, 1
  • [39] Control of Neurotransmission by NaV1.7 in Human, Guinea Pig, and Mouse Airway Parasympathetic Nerves
    Kocmalova, Michaela
    Kollarik, Marian
    Canning, Brendan. J.
    Ru, Fei
    Herbstsomer, R. Adam
    Meeker, Sonya
    Fonquerna, Silvia
    Aparici, Monica
    Miralpeix, Montserrat
    Chi, Xian Xuan
    Li, Baolin
    Wilenkin, Ben
    McDermott, Jeff
    Nisenbaum, Eric
    Krajewski, Jeffrey L.
    Undem, Bradley J.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2017, 361 (01): : 172 - 180
  • [40] Neuropathische Schmerzen durch Nav1.7-MutationenKlinik und TherapieNeuropathic pain associated with Nav1.7 mutationsClinical picture and treatment
    K. Doppler
    C. Sommer
    Der Nervenarzt, 2013, 84 : 1428 - 1435